P

Daniel Smith

Chief Technology Officer at Achira

Overview

Daniel Smith serves as Chief Technology Officer at Achira as of January 2025[1][2]. Smith holds a Doctor of Philosophy in Computational Chemistry from Auburn University, earned between 2011 and 2015[10], and a Bachelor of Science in Biochemistry from the College of Charleston, completed between 2006 and 2010[11]. Smith completed a postdoctoral fellowship in Chemistry at Georgia Institute of Technology from January 2016 to March 2017[9]. Prior to the current role, Smith worked as Vice President, Head of Computation at Abiologics from October 2024 to January 2025[4], and as Senior Director, Head of Computation at the same organization from December 2022 to September 2024[5]. Smith co-founded Iambic Therapeutics and served as Director of Software from April 2020 to December 2022[6]. Smith also served as Software Scientist at The Molecular Sciences Software Institute from March 2017 to April 2020[8] and as Advisor to the Open Force Field Initiative from January 2019 to April 2020[7]. Smith joined the Board of the Open Molecular Software Foundation in October 2025[3].

Career history

  1. Chief Technology OfficerJan 2025 to presentAchira
  2. Board MemberOct 2025 to presentOpen Molecular Software Foundation
  3. Vice President, Head of ComputationSep 2024 to Jan 2025Abiologics
  4. Senior Director, Head of ComputationDec 2022 to Sep 2024Abiologics
  5. Co-founder and Director of SoftwareApr 2020 to Dec 2022Iambic Therapeutics
  6. AdvisorJan 2019 to Apr 2020Open Force Field Initiative
  7. Software ScientistMar 2017 to Apr 2020The Molecular Sciences Software institute

Education

  1. Post-Doc, ChemistryJan 2016 - Mar 2017Georgia Institute of Technology
  2. Doctor of Philosophy (Ph.D.), Computational Chemistry2011 - 2015Auburn University
  3. Bachelor of Science (BS), Biochemistry2006 - 2010College of Charleston

This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.